$2.56T
Total marketcap
$178.43B
Total volume
BTC 50.05%     ETH 15.82%
Dominance

WuXi Biologics (Cayman) WXXWY Stock

3.6 USD {{ price }} -0.552486% {{change_pct}}%
Exchange
Other OTC
Market Cap
7.88B USD
LOW - HIGH [24H]
3.59 - 3.7 USD
VOLUME [24H]
178.01K USD
{{ volume }}
P/E Ratio
13.33
Earnings per share
0.27 USD

WuXi Biologics (Cayman) Price Chart

WuXi Biologics (Cayman) WXXWY Financial and Trading Overview

WuXi Biologics (Cayman) stock price 3.6 USD
Previous Close 11.49 USD
Open 12.11 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 12.02 - 12.19 USD
52 Week Range 8.7 - 21.54 USD
Volume 91.58K USD
Avg. Volume 67.41K USD
Market Cap 25.75B USD
Beta (5Y Monthly) 1.242145
PE Ratio (TTM) 40.63333
EPS (TTM) 0.27 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

WXXWY Valuation Measures

Enterprise Value 22.63B USD
Trailing P/E 40.63333
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6866548
Price/Book (mrq) 0.73477995
Enterprise Value/Revenue 1.482
Enterprise Value/EBITDA 4.464

Trading Information

WuXi Biologics (Cayman) Stock Price History

Beta (5Y Monthly) 1.242145
52-Week Change -27.78%
S&P500 52-Week Change 20.43%
52 Week High 21.54 USD
52 Week Low 8.7 USD
50-Day Moving Average 11.81 USD
200-Day Moving Average 13.34 USD

WXXWY Share Statistics

Avg. Volume (3 month) 67.41K USD
Avg. Daily Volume (10-Days) 40.99K USD
Shares Outstanding 2.11B
Float 1.81B
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0.0069%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 28.94%
Operating Margin (ttm) 28.49%
Gross Margin 44.03%
EBITDA Margin 33.19%

Management Effectiveness

Return on Assets (ttm) 5.80%
Return on Equity (ttm) 13.20%

Income Statement

Revenue (ttm) 15.27B USD
Revenue Per Share (ttm) 7.32 USD
Quarterly Revenue Growth (yoy) 37.00%
Gross Profit (ttm) N/A
EBITDA 5.07B USD
Net Income Avi to Common (ttm) 4.42B USD
Diluted EPS (ttm) 0.3
Quarterly Earnings Growth (yoy) 21.89%

Balance Sheet

Total Cash (mrq) 8.71B USD
Total Cash Per Share (mrq) 4.13 USD
Total Debt (mrq) 4.42B USD
Total Debt/Equity (mrq) 12.21 USD
Current Ratio (mrq) 1.982
Book Value Per Share (mrq) 16.59

Cash Flow Statement

Operating Cash Flow (ttm) 5.54B USD
Levered Free Cash Flow (ttm) -594393984 USD

Profile of WuXi Biologics (Cayman)

Country United States
State N/A
City Wuxi
Address No. 108, Meiliang Road
ZIP 214092
Phone N/A
Website https://www.wuxibiologics.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 12373

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company was incorporated in 2014 and is headquartered in Wuxi, China.

Q&A For WuXi Biologics (Cayman) Stock

What is a current WXXWY stock price?

WuXi Biologics (Cayman) WXXWY stock price today per share is 3.6 USD.

How to purchase WuXi Biologics (Cayman) stock?

You can buy WXXWY shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for WuXi Biologics (Cayman)?

The stock symbol or ticker of WuXi Biologics (Cayman) is WXXWY.

Which industry does the WuXi Biologics (Cayman) company belong to?

The WuXi Biologics (Cayman) industry is Biotechnology.

How many shares does WuXi Biologics (Cayman) have in circulation?

The max supply of WuXi Biologics (Cayman) shares is 2.19B.

What is WuXi Biologics (Cayman) Price to Earnings Ratio (PE Ratio)?

WuXi Biologics (Cayman) PE Ratio is 13.33333200 now.

What was WuXi Biologics (Cayman) earnings per share over the trailing 12 months (TTM)?

WuXi Biologics (Cayman) EPS is 0.27 USD over the trailing 12 months.

Which sector does the WuXi Biologics (Cayman) company belong to?

The WuXi Biologics (Cayman) sector is Healthcare.